Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I H Hall

Showing results (211-220 of 266) with videos related to

Pageof 27
Sort By:
Metal-Based Drugs|January 1, 1996
Boronated pyrimidines and purines as cytotoxic, hypolipidemic and anti-inflammatory agentsI H Hall, B S Burnham, A Elkins, et al.
Biochimica Et Biophysica Acta|June 24, 1983
Selective inactivation of rabbit reticulocyte initiation factor eIF-3 by helenalinW L Williams, S G Chaney, W Willingham, et al.
Journal of Pharmaceutical Sciences|October 1, 1981
Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cellsI H Hall, K H Lee, M Okano, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Relationship between amine-carboxyboranes and TNF alpha for the regulation of cell growth in different tumor cell linesM C Miller, C M Woods, M E Murphy, et al.
Journal of Medicinal Chemistry|August 1, 1981
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agentsK H Lee, T Ibuka, D Sims, et al.
Die Pharmazie|November 1, 1992
The synthesis and anti-neoplastic activity of N2-isobutyryl-2'-deoxyguanosine-N7-cyanoborane derivativesA Sood, B R Shaw, B F Spielvogel, et al.
Anticancer Research|May 1, 1995
The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell linesB S Burnham, S Y Chen, A Sood, et al.
Journal of Pharmaceutical Sciences|August 1, 1995
The disposition, tissue distribution, and cellular transport of N-[[(trimethylamino)boryl]carbonyl]-L-phenylalanine methyl ester in CF1 miceM C Miller, R P Shrewsbury, A L Elkins, et al.
Journal of Pharmaceutical Sciences|March 1, 1981
Antihyperlipidemic activity of amine cyanoboranes, amine carboxyboranes, and related compoundsI H Hall, M K Das, F Harchelroad, et al.
Journal of Pharmaceutical Sciences|June 1, 1979
Boron betaine analogs: antitumor activity and effects on Ehrlich ascites tumor cell metabolismI H Hall, C O Starnes, B F Spielvogel, et al.
Pageof 27

Showing results (211-220 of 266) with videos related to

Sort By:
Pageof 27
Metal-Based Drugs|January 1, 1996
Boronated pyrimidines and purines as cytotoxic, hypolipidemic and anti-inflammatory agentsI H Hall, B S Burnham, A Elkins, et al.
Biochimica Et Biophysica Acta|June 24, 1983
Selective inactivation of rabbit reticulocyte initiation factor eIF-3 by helenalinW L Williams, S G Chaney, W Willingham, et al.
Journal of Pharmaceutical Sciences|October 1, 1981
Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cellsI H Hall, K H Lee, M Okano, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
Relationship between amine-carboxyboranes and TNF alpha for the regulation of cell growth in different tumor cell linesM C Miller, C M Woods, M E Murphy, et al.
Journal of Medicinal Chemistry|August 1, 1981
Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agentsK H Lee, T Ibuka, D Sims, et al.
Die Pharmazie|November 1, 1992
The synthesis and anti-neoplastic activity of N2-isobutyryl-2'-deoxyguanosine-N7-cyanoborane derivativesA Sood, B R Shaw, B F Spielvogel, et al.
Anticancer Research|May 1, 1995
The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell linesB S Burnham, S Y Chen, A Sood, et al.
Journal of Pharmaceutical Sciences|August 1, 1995
The disposition, tissue distribution, and cellular transport of N-[[(trimethylamino)boryl]carbonyl]-L-phenylalanine methyl ester in CF1 miceM C Miller, R P Shrewsbury, A L Elkins, et al.
Journal of Pharmaceutical Sciences|March 1, 1981
Antihyperlipidemic activity of amine cyanoboranes, amine carboxyboranes, and related compoundsI H Hall, M K Das, F Harchelroad, et al.
Journal of Pharmaceutical Sciences|June 1, 1979
Boron betaine analogs: antitumor activity and effects on Ehrlich ascites tumor cell metabolismI H Hall, C O Starnes, B F Spielvogel, et al.
Pageof 27